JPS5697237A - Antibiotic aa16686 and its manufacture - Google Patents

Antibiotic aa16686 and its manufacture

Info

Publication number
JPS5697237A
JPS5697237A JP4476480A JP4476480A JPS5697237A JP S5697237 A JPS5697237 A JP S5697237A JP 4476480 A JP4476480 A JP 4476480A JP 4476480 A JP4476480 A JP 4476480A JP S5697237 A JPS5697237 A JP S5697237A
Authority
JP
Japan
Prior art keywords
antibiotic
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4476480A
Other languages
English (en)
Other versions
JPS6251274B2 (ja
Inventor
Kabarureri Buruuno
Pagani Herumesu
Buorupe Giankaruro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of JPS5697237A publication Critical patent/JPS5697237A/ja
Publication of JPS6251274B2 publication Critical patent/JPS6251274B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00—Catalysts comprising molecular sieves
    • B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28—Base exchange silicates, e.g. zeolites
    • C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00—Reforming naphtha
    • C10G35/04—Catalytic reforming
    • C10G35/06—Catalytic reforming characterised by the catalyst used
    • C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes
JP4476480A 1979-04-07 1980-04-07 Antibiotic aa16686 and its manufacture Granted JPS5697237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (2)

Publication Number Publication Date
JPS5697237A true JPS5697237A (en) 1981-08-05
JPS6251274B2 JPS6251274B2 (ja) 1987-10-29

Family

ID=10504421

Family Applications (2)

Application Number Title Priority Date Filing Date
JP4476480A Granted JPS5697237A (en) 1979-04-07 1980-04-07 Antibiotic aa16686 and its manufacture
JP62088966A Granted JPS62282579A (ja) 1979-04-07 1987-04-13 抗生物質ａ／１６６８６生産菌

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62088966A Granted JPS62282579A (ja) 1979-04-07 1987-04-13 抗生物質ａ／１６６８６生産菌

Country Status (30)

Country Link
US (2) US4303646A (ja)
JP (2) JPS5697237A (ja)
AR (1) AR222217A1 (ja)
AT (1) AT370130B (ja)
AU (2) AU533951B2 (ja)
BE (1) BE882632A (ja)
CA (1) CA1142866A (ja)
CH (1) CH655515B (ja)
DE (1) DE3013246A1 (ja)
DK (1) DK149336C (ja)
ES (1) ES8103170A1 (ja)
FI (1) FI65630C (ja)
FR (1) FR2452931A1 (ja)
GR (1) GR67279B (ja)
HK (1) HK23584A (ja)
HU (1) HU181534B (ja)
IE (1) IE49327B1 (ja)
IL (1) IL59704A (ja)
IT (1) IT1212411B (ja)
LU (1) LU82327A1 (ja)
MX (1) MX5958E (ja)
NL (1) NL192989C (ja)
NO (1) NO155496C (ja)
NZ (1) NZ193357A (ja)
PH (1) PH17230A (ja)
PT (1) PT71064A (ja)
SE (1) SE441188B (ja)
SG (1) SG22687G (ja)
YU (1) YU41917B (ja)
ZA (1) ZA801629B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7031T1 (de) 1980-08-16 1984-04-15 Gruppo Lepetit S.P.A. Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3.
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US20030113715A1 (en) * 2000-01-21 2003-06-19 Daniel Santi Method for cloning polyketide synthase genes
US7078185B2 (en) * 2000-10-13 2006-07-18 Ecopia Biosciences Inc. Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
JP2005529852A (ja) 2002-03-08 2005-10-06 ビクロン・フアーマシユーチカルズ・インコーポレーテツド ラモプラニン−様アミド誘導体の製造法
WO2003089641A2 (en) * 2002-04-17 2003-10-30 Ecopia Biosciences Inc. Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
US7317001B2 (en) * 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
WO2004096143A2 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
WO2015161074A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
NL192989B (nl) 1998-03-02
AU533951B2 (en) 1983-12-22
FI800881A (fi) 1980-10-08
ZA801629B (en) 1981-03-25
AU5903680A (en) 1980-12-11
IT8021162A0 (it) 1980-04-03
MX5958E (es) 1984-09-06
IL59704A (en) 1983-11-30
FI65630C (fi) 1984-06-11
AU5703680A (en) 1980-10-09
NL192989C (nl) 1998-07-03
AU535727B2 (en) 1984-04-05
HK23584A (en) 1984-03-23
IL59704A0 (en) 1980-06-30
DK149336B (da) 1986-05-05
NL8001982A (nl) 1980-10-09
CH655515B (ja) 1986-04-30
US4303646A (en) 1981-12-01
JPS6320514B2 (ja) 1988-04-27
JPS6251274B2 (ja) 1987-10-29
YU93580A (en) 1983-06-30
DE3013246A1 (de) 1980-10-16
ATA187480A (de) 1982-07-15
AR222217A1 (es) 1981-04-30
DK149336C (da) 1986-10-13
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
IE800697L (en) 1980-10-07
HU181534B (en) 1983-10-28
SE441188B (sv) 1985-09-16
FR2452931A1 (fr) 1980-10-31
PH17230A (en) 1984-07-03
ES490236A0 (es) 1981-02-16
FR2452931B1 (ja) 1983-07-01
AT370130B (de) 1983-03-10
SE8002601L (sv) 1980-12-01
IE49327B1 (en) 1985-09-18
ES8103170A1 (es) 1981-02-16
DE3013246C2 (ja) 1987-11-19
SG22687G (en) 1989-07-07
JPS62282579A (ja) 1987-12-08
NZ193357A (en) 1982-12-07
GR67279B (ja) 1981-06-26
NO155496B (no) 1986-12-29
FI65630B (fi) 1984-02-29
IT1212411B (it) 1989-11-22
US4328316A (en) 1982-05-04
CA1142866A (en) 1983-03-15
BE882632A (fr) 1980-10-03
DK140080A (da) 1980-10-08
YU41917B (en) 1988-02-29

Similar Documents

Publication Publication Date Title
JPS5695331A (en) Ferroofluid and its manufacture
JPS5697237A (en) Antibiotic aa16686 and its manufacture
JPS5612370A (en) Substituted 33aryllpyrazole and 33aryllisoxazole and manufacture thereof
JPS5592353A (en) Antibiotic aa21978 and its manufacture
JPS5657797A (en) Antibiotic uu59761
JPS5683488A (en) Antibacterial and its manufacture
JPS5690086A (en) 11piperidinesulfonylurea and its manufacture
JPS55154979A (en) Novel 33vinylcephalosporin and its manufacture
JPS5617245A (en) Long structure and its manufacture
IL60216A0 (en) Antibiotic a-30912 factor h
GB2060629B (en) Antibiotic substance and production and use thereof
JPS54163502A (en) Antibiotic aa38533 and its manufacture
JPS5690094A (en) Hydantoinylsilane and its manufacture
JPS5626862A (en) Novel substituted phenylacetylguanidine and its manufacture
JPS55120627A (en) Novel complex and its manufacture
JPS55124768A (en) Phenylmorphanes*its intermediate and its manufacture
JPS5688861A (en) Construction and its manufacture
JPS5634680A (en) Antibiotic em4940 and its manufacture
JPS55151571A (en) Novel 22isopropylaminoo55halogenopyrimidine and its manufacture
JPS5616441A (en) 44fluoroo33bromoobenzoylfluoride and manufacture thereof
JPS565479A (en) Novel 33substituteddtetrahydropyrrolopyrimidines and their manufacture
JPS55130950A (en) Betaaalkoxyyacrylonitrile*33aminooacryonitrile and 22cyanoovinylester manufacture
JPS55157575A (en) Polyhaloquinoxalinesulfonate* its manufacture and its application
JPS5498701A (en) Antibiotic aa40104 and its manufacture
JPS5659740A (en) N*nndimethylln**isobutyllnnbetaa hydroxyethylpropylenediamine and its manufacture